Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Guelph

$24,467.00

Development of an efficient and environmentally friendly process for production of Buproprion

EF 2014-15

Résumé
Bupropion, known mostly on the market as Wellbutrin(TM) and Zyban(TM) is used extensively as antidepressant with US estimated sales of >$400 million in 2011, making it one of the most common antidepressants in the USA. Its mode of action is thought to be as an inhibitor of dopamine reuptake. It has also found use as an anti-obesity drug, for the treatment of attention deficit hyperactivity disorder (ADHD), to address neuropathic pain and for smoking cessation. The drug has also been used to treat substance dependency.The modern chemical literature suggests that this compound can be prepared more expeditiously than covered in the patent process. As such, the plan is to evaluate three related experimental methodologies in order to determine if they are applicable to the expeditious preparation of Bupropion, while producing fewer and more innocuous by-products. A successful study and adaptation of the outcomes to industrial scale will facilitate the first Canadian production of this important drug entity.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
477709-2014
Name nom
Schwan, Adrian
Department département
Chemistry
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
24467
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Development of an efficient and environmentally friendly process for production of Buproprion
Keyword
NSERC
Application summary
Bupropion, known mostly on the market as Wellbutrin(TM) and Zyban(TM) is used extensively as antidepressant with US estimated sales of >$400 million in 2011, making it one of the most common antidepressants in the USA. Its mode of action is thought to be as an inhibitor of dopamine reuptake. It has also found use as an anti-obesity drug, for the treatment of attention deficit hyperactivity disorder (ADHD), to address neuropathic pain and for smoking cessation. The drug has also been used to treat substance dependency.The modern chemical literature suggests that this compound can be prepared more expeditiously than covered in the patent process. As such, the plan is to evaluate three related experimental methodologies in order to determine if they are applicable to the expeditious preparation of Bupropion, while producing fewer and more innocuous by-products. A successful study and adaptation of the outcomes to industrial scale will facilitate the first Canadian production of this important drug entity.